Immunoglobulins |
IgE Induces Airway Smooth Muscle Cell
Proliferation |
Disease |
0.05 |
0.02 |
>0.05 |
|
V(D)J Recombination Activation |
Biological process |
>0.05 |
0.01 |
0.01 |
|
IgE Receptors -> Targets in Lymphoid System and Blood |
Biomarkers |
>0.05 |
>0.05 |
0.01 |
Interleukins |
IL3 Expression Targets |
Biomarkers |
0.04 |
0.02 |
0.03 |
|
IL17F Signaling in Bronchial Epithelial Cell in Asthma |
Disease |
0.02 |
>0.05 |
>0.05 |
|
IL4 Expression Targets |
Biomarkers |
>0.05 |
>0.05 |
<0.01 |
|
IL10/STAT3 Signaling in M2 Macrophage and Retinal Angiogenesis |
Disease |
>0.05 |
>0.05 |
0.04 |
|
IL17 Signaling in Psoriasis |
Disease |
>0.05 |
>0.05 |
0.02 |
CD molecules |
CD80 -> STAT Expression Targets |
Biomarkers |
>0.05 |
0.02 |
>0.05 |
|
CD86 -> STAT Expression Targets |
Biomarkers |
>0.05 |
0.03 |
>0.05 |
|
CD80 -> NF-kB Expression Targets |
Biomarkers |
>0.05 |
0.04 |
>0.05 |
|
CD38/CD19 -> JUN/FOS/NF-kB Signaling in B-cell
Proliferation |
Signal processing |
>0.05 |
0.03 |
>0.05 |
|
CD38 -> cADPR/Calcium Signaling |
Signal processing |
0.04 |
>0.05 |
>0.05 |
|
CD157 -> cADPR/Calcium Signaling |
Signal processing |
0.01 |
<0.01 |
>0.05 |
Mast cells |
Mast-Cells Activation in Atopic Dermatitis |
Disease |
0.02 |
0.01 |
>0.05 |
|
Mast-Cell Activation without Degranulation through CRHR1 Signaling |
Biological processes |
0.01 |
>0.05 |
>0.05 |
Receptor tyrosine kinases |
VEGFA -> FOXO3A
Expression Targets |
Biomarkers |
>0.05 |
0.01 |
>0.05 |
|
VEGFR -> FOXO3A Signaling |
Signalling processes |
0.04 |
0.01 |
>0.05 |
|
TGFA -> FOXO3A Expression Targets |
Biomarkers |
>0.05 |
>0.05 |
0.01 |
|
HBEGF -> FOXO3A Expression Target |
Biomarkers |
>0.05 |
>0.05 |
0.01 |
|
EREG -> FOXO3A Expression Target |
Biomarkers |
>0.05 |
>0.05 |
0.02 |